Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismail Labgaa

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
Oncogene|October 24, 2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinomaJohann von Felden, Amanda J Craig, Teresa Garcia-Lezana, et al.
Journal of Surgical Oncology|December 8, 2020
Early postoperative decrease of albumin is an independent predictor of major complications after oncological esophagectomy: A multicenter studyIsmail Labgaa, Styliani Mantziari, Maxime Genety, et al.
The British Journal of Surgery|April 17, 2024
Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre studyGaëtan-Romain Joliat, Robert de Man, Vincent Rijckborst, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 11, 2025
First results from the international registry on liver venous deprivation (EuroLVD)Gaëtan-Romain Joliat, Patrick Chevallier, Stephen Wigmore, et al.
Oncogene|April 10, 2018
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinomaIsmail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, et al.
Plos Genetics|June 24, 2021
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinomaAmanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta, et al.
Journal of Hepatology|March 17, 2020
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Daniela Sia, Carla Montironi, et al.
Nature Communications|January 17, 2020
Intratumoral heterogeneity and clonal evolution in liver cancerBojan Losic, Amanda J Craig, Carlos Villacorta-Martin, et al.
Gut|July 29, 2021
Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancerJohann von Felden, Teresa Garcia-Lezana, Navneet Dogra, et al.
JHEP Reports : Innovation in Hepatology|April 28, 2025
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesisKornelius Schulze, Tim Daniel Rose, Lorenz Adlung, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
Oncogene|October 24, 2020
Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinomaJohann von Felden, Amanda J Craig, Teresa Garcia-Lezana, et al.
Journal of Surgical Oncology|December 8, 2020
Early postoperative decrease of albumin is an independent predictor of major complications after oncological esophagectomy: A multicenter studyIsmail Labgaa, Styliani Mantziari, Maxime Genety, et al.
The British Journal of Surgery|April 17, 2024
Long-term outcomes of ruptured hepatocellular carcinoma: international multicentre studyGaëtan-Romain Joliat, Robert de Man, Vincent Rijckborst, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|May 11, 2025
First results from the international registry on liver venous deprivation (EuroLVD)Gaëtan-Romain Joliat, Patrick Chevallier, Stephen Wigmore, et al.
Oncogene|April 10, 2018
A pilot study of ultra-deep targeted sequencing of plasma DNA identifies driver mutations in hepatocellular carcinomaIsmail Labgaa, Carlos Villacorta-Martin, Delia D'Avola, et al.
Plos Genetics|June 24, 2021
Transcriptomic characterization of cancer-testis antigens identifies MAGEA3 as a driver of tumor progression in hepatocellular carcinomaAmanda J Craig, Teresa Garcia-Lezana, Marina Ruiz de Galarreta, et al.
Journal of Hepatology|March 17, 2020
Molecular classification and therapeutic targets in extrahepatic cholangiocarcinomaRobert Montal, Daniela Sia, Carla Montironi, et al.
Nature Communications|January 17, 2020
Intratumoral heterogeneity and clonal evolution in liver cancerBojan Losic, Amanda J Craig, Carlos Villacorta-Martin, et al.
Gut|July 29, 2021
Unannotated small RNA clusters associated with circulating extracellular vesicles detect early stage liver cancerJohann von Felden, Teresa Garcia-Lezana, Navneet Dogra, et al.
JHEP Reports : Innovation in Hepatology|April 28, 2025
Metabolomic liquid biopsy dynamics predict early-stage HCC and actionable candidates of human hepatocarcinogenesisKornelius Schulze, Tim Daniel Rose, Lorenz Adlung, et al.
Pageof 10